Back
W.W. Grainger Vs. Kymera Therapeutics Industry Stock Comparison
Sell
50
GWW
W.W. Grainger
Last Price:
949.20
Seasonality Move:
2.98%
Buy
62
KYMR
Kymera Therapeutics
Last Price:
41.87
Seasonality Move:
-9.55%
Sell
50
W.W. Grainger (GWW)
is a Sell
Is W.W. Grainger a Buy, Sell or Hold?
- The current W.W. Grainger [GWW] share price is $961.14. The Score for GWW is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- GWW is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $43.00. The Score for KYMR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GWW Stock Price Chart
What is W.W. Grainger's stock price today?
-
The W.W. Grainger share price today is $961.14
The current trend is moderately bearish and GWW is experiencing buying pressure, which is a positive indicator for future bullish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $43.00
The current trend is moderately bullish and KYMR is experiencing slight buying pressure.
GWW Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.44 | Buy |
| Relative Strength Index (14 RSI): | 53.71 | Buy |
| Chaikin Money Flow: | 186499 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (932.16 - 973.9) | Buy |
| Bollinger Bands (100): | (911.29 - 981.77) | Buy |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.04 | Buy |
| Relative Strength Index (14 RSI): | 55.08 | Buy |
| Chaikin Money Flow: | 127907 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.38 - 45.36) | Buy |
| Bollinger Bands (100): | (32.42 - 41.32) | Buy |
GWW Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 959.84 | Buy |
| 20-day SMA: | 958.46 | Buy |
| 50-day SMA: | 929.68 | Buy |
| 200-day SMA: | 905.82 | Buy |
| 8-day EMA: | 961.76 | Sell |
| 20-day EMA: | 954.8 | Buy |
| 50-day EMA: | 943.73 | Buy |
| 200-day EMA: | 894.55 | Buy |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.54 | Buy |
| 20-day SMA: | 43.04 | Sell |
| 50-day SMA: | 37.57 | Buy |
| 200-day SMA: | 32.59 | Buy |
| 8-day EMA: | 42.23 | Buy |
| 20-day EMA: | 41.74 | Buy |
| 50-day EMA: | 39.34 | Buy |
| 200-day EMA: | 33.93 | Buy |
W.W. Grainger Earnings Growth & GWW Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.13 per share, an increase next quarter of $1.01 per share, an increase this year of $2.37 per share, and an increase next year of $3.55 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.12 per share, a decrease this year of $0.25 per share, and a decrease next year of $0.33 per share.
W.W. Grainger Technical Analysis
| Jul 31 | Aug 1 | Aug 2 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 9 | Aug 12 | Aug 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | Aug | |||||||||
| 31 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics Technical Analysis
| Jul 31 | Aug 1 | Aug 2 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 9 | Aug 12 | Aug 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | Aug | |||||||||
| 31 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||